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A 71-year-old man was scheduled to undergo cardiac resynchronization therapy device (CRTD) implantation. He was
combined with severe chronic heart failure due to ischemic heart disease. NYHA class was 3 to 4 and electrocardiogram
showed non-sustained ventricular. Ejection fraction was about 20% revealed by transthoracic echocardiogram. He was
also on several anticoagulation medications. We planned to implant the device under the greater pectoral muscle. As
general anesthesia was considered risky, monitored anesthesia care utilizing peripheral nerve block and slight sedation
was scheduled. Pectoral nerves (PECS) block and intercostal block was performed under ultrasonography with
ropivacaine. For sedation during the procedure, continuous infusion of dexmedetomidine without a loading dose
was performed. The procedure lasted about 3 hours, but the patient showed no pain or restlessness. Combination
of PECS block and intercostal block may provide effective analgesia for CRTD implantation.
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Effective analgesia and sedation during cardiac resynchroni-
zation therapy device (CRTD) implantation is important
from the perspectives of surgical procedure and circulation
stability (Looi et al. 2013).
The pectoral nerves (PECS) block is relatively easy and
reliable peripheral nerve block which was inspired by
the transversus abdominis plane block and the brachial
plexus block with infraclavicular approach (Blanco 2011).
PECS block targets the lateral and median pectoral nerves
at an interfascial plane between the pectoralis major and
minor muscles (Porzionato et al. 2012). The main indica-
tions are breast surgery by tissue expanders or subpectoral
prosthesis because the distension of these muscles is
rather painful (Blanco 2011) (Blanco et al. 2012).
Here we report the successful application of pectoral
nerves (PECS) and intercostal nerve block for CRTD
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A 71-year-old man (height, 154 cm; weight, 41 kg) was
scheduled to undergo CRTD implantation. He suffered
from chronic heart failure due to ischemic heart disease.
NYHA class was 3 to 4 and nonsustained ventricular
tachycardia was observed. Transthoracic echocardiog-
raphy showed an ejection fraction of 20%. He was also
on several anticoagulation medications. We planned to
implant the device under the greater pectoral muscle. As
general anesthesia was considered risky, monitored anes-
thesia care with peripheral nerve block and slight sedation
was scheduled.
Intercostal nerve block at the level of the first and
second intercostal space was performed under ultrason-
ography with 4 ml of 0.375% ropivacaine. With linear
ultrasound probe positioning similar place when per-
forming an infraclavicular brachial plexus block. After
identifying the pectoralis major muscle, we checked the
location of the pectoral branch of the thoracio-acromial
artery between the pectoralis muscles with colour Doppler.
Then, we placed 10 ml of 0.375% ropivacaine into the
interfascial plane between pectoralis major and minor
muscles (Blanco 2011). The puncture point of the PECS
block needle was 2–3 cm from the surgical point.an Open Access article distributed under the terms of the Creative Commons
g/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction
roperly credited.
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of 0.4 μg・kg−1・h−1 dexmedetomidine without a loading
dose was performed. The procedure lasted about 3 hours,
but the patient showed no pain or restlessness. Also, no
significant hemodynamic change such as heart rate and
blood pressure was admitted (within 10 percent).
Discussion and evaluation
Analgesia and sedation during CRTD implantation is
often challenging, as systemic administration of sedatives
and analgesics can disturb circulation (Looi et al. 2013).
PECS block is a relatively new peripheral nerve block
strategy for breast surgery pain management (Blanco 2011)
(Blanco et al. 2012). With PECS and Intercostal nerve
block, we can not only provide effective analgesia for
relatively long procedures but also avoid the risk of
local anesthetic intoxication. Too much local anesthetic
administration may lead to the insufficient wound healing,
local anesthetic intoxication leading to patient stress
(Butterworth 2010). With PECS and intercostal nerve
block, we could minimize the dose of local anesthetics
under the guide of ultrasonography. However, as there
is a risk of peripheral nerve injury by the block needle, we
should pay thorough attention during the procedure.
We utilized dexmedetomidine as the sedatives during
the procedure. Effect of dexmedetomidine to circulatory
and respiratory suppression is relatively smaller compared
to propofol (Curtis et al. 2013). Combination of peripheral
nerve block and dexmedetomidine sedation may be bene-
ficial for monitored anesthesia care in patients with severe
cardiopulmonary problems.
Conclusion
Our findings suggest that a combination of PECS block
and intercostal nerve block can provide effective analgesia
for CRTD implantation.
Patient consent
Written consent was obtained from the patient for the
publication of this report.
Competing interests
The authors have no affiliation with any manufacturer of any device
described in the manuscript and declare no financial interest in relation to
the material described here.
Authors’ contributions
AF and NK performed anesthesic management of the case, and wrote the
manuscript; TM: prepared the manuscript preparation, critical comment and
final approval. All authors read and approved the final manuscript.
Source of funding statements
Financial support for the study was provided by our institution and department.
Received: 15 July 2014 Accepted: 29 July 2014
Published: 5 August 2014References
Blanco R (2011) The ‘pecs block’: a novel technique for providing analgesia after
breast surgery. Anaesthesia 66:847–848
Blanco R, Fajardo M, Parras Maldonado T (2012) Ultrasound description of Pecs II
(modified Pecs I): a novel approach to breast surgery. Rev Esp Anestesiol
Reanim 59:470–475
Butterworth JF 4th (2010) Models and mechanisms of local anesthetic cardiac
toxicity: a review. Reg Anesth Pain Med 35:167–176
Curtis JA, Hollinger MK, Jain HB (2013) Propofol-based versus dexmedetomidine-
based sedation in cardiac surgery patients. J Cardiothorac Vasc Anesth
27:1289–1294
Looi KL, Lee AS, Cole K, Agarwal S, Heck PM, Begley DA, Grace AA, Virdee M,
Fynn SP (2013) Conscious sedation and analgesia use in cardiac device
implantation. Int J Cardiol 168:561–563
Porzionato A, Porzionato A, Macchi V, Stecco C, Loukas M, Tubbs RS, De Caro R
(2012) Surgical anatomy of the pectoral nerves and the pectoral musculature.
Clin Anat 25:559–575
doi:10.1186/2193-1801-3-409
Cite this article as: Fujiwara et al.: Pectoral nerves (PECS) and intercostal
nerve block for cardiac resynchronization therapy device implantation.
SpringerPlus 2014 3:409.Submit your manuscript to a 
journal and beneﬁ t from:
7 Convenient online submission
7 Rigorous peer review
7 Immediate publication on acceptance
7 Open access: articles freely available online
7 High visibility within the ﬁ eld
7 Retaining the copyright to your article
    Submit your next manuscript at 7 springeropen.com
